MedTrace Logo

Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases

NCT04530461 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2020-09-22

No results posted yet for this study

Summary

An observational study aiming to assess the serological profile of SARS-Cov2 patients with systemic diseases such as systemic lupus erythematosus, Sjogren syndrome, sarcoidosis, inflammatory myopathies, Behçet's disease, Rheumatoid arthritis and Spondyloarthritis

Conditions

Interventions

DIAGNOSTIC_TEST

Serological test

Positive serological test of SARS Cov2

Sponsors & Collaborators

  • UR17DN02 : Autoimmune Diseases Research Unit

    collaborator UNKNOWN

  • faida agili

    lead OTHER

Principal Investigators

  • Faida Ajili, MD · Military Hospital of Tunis

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2020-11-30
Completion
2021-01-31

Countries

  • Tunisia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04530461 on ClinicalTrials.gov